These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27727218)

  • 1. The emerging patent landscape of CRISPR-Cas gene editing technology.
    Egelie KJ; Graff GD; Strand SP; Johansen B
    Nat Biotechnol; 2016 Oct; 34(10):1025-1031. PubMed ID: 27727218
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR patent estate splinters.
    Sheridan C
    Nat Biotechnol; 2017 Sep; 35(9):808-809. PubMed ID: 28898216
    [No Abstract]   [Full Text] [Related]  

  • 3. CRISPR heavyweights battle in US patent court.
    Reardon S
    Nature; 2016 Dec; 540(7633):326-327. PubMed ID: 27974781
    [No Abstract]   [Full Text] [Related]  

  • 4. Racing for academic glory and patents: Lessons from CRISPR.
    Rai AK; Cook-Deegan R
    Science; 2017 Nov; 358(6365):874-876. PubMed ID: 29146800
    [No Abstract]   [Full Text] [Related]  

  • 5. EPO revokes Broad's CRISPR patent.
    Harrison C
    Nat Biotechnol; 2018 Mar; 36(3):209. PubMed ID: 29509734
    [No Abstract]   [Full Text] [Related]  

  • 6. Broad Institute wins bitter battle over CRISPR patents.
    Ledford H
    Nature; 2017 Feb; 542(7642):401. PubMed ID: 28230140
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR-Cas9 claim sets and the potential to stifle innovation.
    Gray BN; Spruill WM
    Nat Biotechnol; 2017 Jul; 35(7):630-633. PubMed ID: 28700549
    [No Abstract]   [Full Text] [Related]  

  • 8. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of OECD activities related to modern techniques of biotechnology and genome editing : OECD conference on genome editing, June 2018.
    Kearns P
    Transgenic Res; 2019 Aug; 28(Suppl 2):41-44. PubMed ID: 31321681
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR, surrogate licensing, and scientific discovery.
    Contreras JL; Sherkow JS
    Science; 2017 Feb; 355(6326):698-700. PubMed ID: 28209863
    [No Abstract]   [Full Text] [Related]  

  • 11. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waive CRISPR patents to meet food needs in low-income countries.
    van der Oost J; Fresco LO
    Nature; 2021 Sep; 597(7875):178. PubMed ID: 34489579
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR plants now subject to tough GM laws in European Union.
    Callaway E
    Nature; 2018 Aug; 560(7716):16. PubMed ID: 30065322
    [No Abstract]   [Full Text] [Related]  

  • 15. The CRISPR Patent Ruling and Implications for Medicine.
    Paradise J
    JAMA; 2023 Feb; 329(6):461-462. PubMed ID: 36637817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption and development: the evolving CRISPR patent and technology landscape.
    Lim D
    Pharm Pat Anal; 2018 Jul; 7(4):141-145. PubMed ID: 29882718
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent patents in endonucleases and genome editing.
    Nat Biotechnol; 2018 Nov; 36(11):1048. PubMed ID: 30412205
    [No Abstract]   [Full Text] [Related]  

  • 18. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.
    Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S
    Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property education exemplified by the patents on the CRISPR/Cas9 system.
    Fan X; Liao G; Xie J
    Yi Chuan; 2014 Dec; 36(12):1269-73. PubMed ID: 25487273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR, Patents, and the Public Health.
    Sherkow JS
    Yale J Biol Med; 2017 Dec; 90(4):667-672. PubMed ID: 29259531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.